Secondary fracture and mortality risk with very high fracture risk osteoporosis and proximal femoral fracture

• DOI: 10.1007/s00774-023-01492-1
• Publication Date: 2024-02-03T08:02:51Z
• Authors: Hotaka Ishizu; Tomohiro Shimizu; Kosuke Arita; Komei Sato; Renya Takahashi; Kenichi Kusunoki; Shun Shimodan; Tsuyoshi Asano; Norimasa Iwasaki
• Keywords: Hip Fracture

We aimed to investigate secondary fracture and mortality rates, and risk factors in patients with proximal femoral fractures.We conducted a multicenter prospective cohort study on female patients with proximal femoral fractures who underwent surgical treatment between April 2020 and March 2021. Postoperative follow-ups were performed at 6-, 12-, 18-, and 24-month intervals to determine the secondary fracture and mortality rates, and the risk factors and its influence were examined.Of the 279 registered patients, 144 patients (51.6%) were diagnosed with very high fracture risk osteoporosis. The postoperative osteoporosis rate exceeded 96%; however, osteoanabolic agents were used sparingly. The risk factor of both secondary fracture and mortality was very high fracture risk osteoporosis, and secondary fractures within 12 months were markedly occurred. Secondary fracture rates increased as the number of matched very high fracture risk osteoporosis criteria increased. Notably, secondary fractures and mortality were recorded in 21.4% and 23.5% of the patients who met all criteria, respectively.Over half of the female patients with proximal femoral fractures had very high fracture risk osteoporosis. Although, very high fracture risk osteoporosis demonstrated a notably increased risk of secondary fractures, particularly at 12 months post-surgery, the use of osteoanabolic agents was substantially low. Collectively, our findings highlight the need to consider the risk of very high fracture risk osteoporosis, expand the use of medications to include osteoanabolic agents, and reconsider the current healthcare approach for proximal femoral fractures.